Sep 15, 2026 05:22AM
Sep 14, 2026 04:05PM
Sep 14, 2026 04:05PM
Jul 30, 2026 04:05PM
May 5, 2026 04:05PM
Feb 25, 2026 04:05PM
Jan 11, 2026 04:30PM Veracyte Announces Preliminary Fourth Quarter and Full-Year 2025 Results
Nov 4, 2025 04:05PM
Aug 26, 2025 08:35AM
Aug 26, 2025 08:30AM
Aug 6, 2025 04:05PM
Jul 24, 2025 05:58PM
Jul 24, 2025 05:20PM
May 7, 2025 04:05PM Veracyte Announces First Quarter 2025 Financial Results
Feb 24, 2025 04:05PM
Nov 6, 2024 04:05PM
Aug 28, 2024 05:43AM
Aug 6, 2024 04:05PM
May 7, 2024 04:05PM
Feb 22, 2024 04:05PM
Feb 6, 2024 08:15AM Veracyte Completes Acquisition of C2i Genomics
Jan 8, 2024 08:09AM
Jan 8, 2024 08:00AM
Nov 7, 2023 04:05PM
Aug 8, 2023 04:05PM
May 4, 2023 04:05PM
Feb 22, 2023 04:05PM
Nov 2, 2022 04:05PM Veracyte Announces Third Quarter 2022 Financial Results
Aug 2, 2022 04:05PM
May 3, 2022 04:05PM
Feb 28, 2022 04:05PM
Feb 28, 2022 08:30AM
Jan 6, 2022 08:32AM
Jan 6, 2022 08:30AM
Nov 18, 2021 05:03AM Goldman Sachs Reinstates Veracyte, Inc (VCYT) at Buy
Nov 13, 2021 07:00AM
Nov 9, 2021 04:05PM
Nov 5, 2021 08:15AM
Nov 5, 2021 08:15AM
Nov 2, 2021 08:15AM
Aug 3, 2021 08:00AM
Jul 29, 2021 04:05PM Veracyte Announces Second Quarter 2021 Financial Results
Jul 12, 2021 08:32AM
Jul 12, 2021 08:30AM
Jun 25, 2021 10:38AM
Jun 1, 2021 07:02AM
Jun 1, 2021 07:00AM
May 11, 2021 06:34AM
May 10, 2021 04:31PM Veracyte (VCYT) Tops Q1 EPS by 78c, Revenues Beat
May 10, 2021 04:05PM

1,198,936 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All